Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma
{{output}}
Background: At present, neoadjuvant therapy before surgery has important application prospects in esophageal carcinoma (ESCA). However, there is still a lack of effective biomarkers to predict the prognosis of neoadjuvant therapy... ...
